Fexocare Tablets 180mg
Fexocare Tablets 180mg
Regular price
Rs.172.00 PKR
Sale price
Rs.172.00 PKR
Regular price
Shipping calculated at checkout.
Product Overview
Product Form: TabletsPack Size: 30 tablets
Prescription Required: No
Fexocare Tablets 180mg Details
Fexocare Tablets 180mg are a popular over-the-counter allergy medication that provides effective relief from symptoms such as sneezing, runny nose, itching, and watery eyes. Each tablet contains 180mg of the active ingredient, fexofenadine hydrochloride, which is a non-drowsy antihistamine. Fexocare is suitable for adults and children aged 12 years and older, making it a convenient choice for the whole family.Fexocare Tablets 180mg Uses
- Relieves allergy symptoms
- Treats hay fever
- Controls itching due to hives
- Reduces symptoms of allergic skin conditions
How To Use Fexocare Tablets 180mg
For adults and children 12 years and older, take one tablet daily with water. It is recommended to take Fexocare Tablets 180mg with food to enhance absorption and reduce the risk of stomach upset. Do not exceed the recommended dosage unless directed by a healthcare professional.Adverse Effects
While Fexocare Tablets 180mg are generally well-tolerated, some individuals may experience mild side effects such as headache, dizziness, or dry mouth. If any of these effects persist or worsen, seek medical attention promptly.Important Warnings & Precautions
It is essential to read the product label and follow the instructions carefully before using Fexocare Tablets 180mg. Avoid taking this medication with fruit juices, as they may decrease the effectiveness of the drug. If you have a medical condition or are pregnant or breastfeeding, consult your healthcare provider before using Fexocare Tablets 180mg. Keep out of reach of children and store at room temperature away from moisture and heat.Couldn't load pickup availability
Shipping
Shipping
Orders are processed within 24 hours (except weekends & holidays).
All cities near to islamabad delivery: 2-3 day
Other cities: 3-5 days.

